Company Profile
We are the leader in antisense drug development with a broad pipeline of drugs that are applicable to many different disease targets. Our antisense technology provides a direct route from genes to drugs with the opportunity to dramatically improve industry drug discovery productivity.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
7H-Furo[3,2-g][1]benzopyran-7-one,2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, (2S)- |
7H-Furo[3,2-g][1]benzopyran-7-one,2,3-dihydro-2-(1-hydroxy-1-methylethyl)-,(2S)-;Marmesin;7H-Furo[3,2-g][1]benzopyran-7-one,2,3-dihydro-2-(1-hydroxy-1-methylethyl)-,(S)-;7H-Furo[3,2-g][1]benzopyran-7-one,2,3-dihydro-2-(1-hydroxy-1-methylethyl)-,(S)-(+)-;(2S)-2,3-Dihydro-2-(1-hydroxy-1-methylethyl)-7H-furo[3,2-g][1]benzopyran-7-one;(+)-Marmesin;S-(+)-Marmesin;(S)-Marmesin;NSC 340840 |
13849-08-6 | - / 99.8% | Inquiry |
Ansamitocin P 3 |
Maytansine,2′-de(acetylmethylamino)-2′-methyl-;4,24-Dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosane,maytansine deriv.;2′-De(acetylmethylamino)-2′-methylmaytansine;Maytansinol isobutyrate;Ansamitocin P 3;Antibiotic C 15003P3;Ansamitosin P 3;NSC 292222;83541-34-8 |
66584-72-3 | - / 99.8% | Inquiry |
CONTACT INFORMATION
Sign In for Details